What is Terra Innovatum Global's earnings per share (EPS)?

Terra Innovatum Global (NKLR) reported diluted earnings per share of $9.74 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Terra Innovatum Global Financials

NKLR

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Terra Innovatum Global (NKLR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NKLR FY2025 2026-07-01

A financing-led balance-sheet build left the company cash-rich in the short term but still carrying deep negative equity.

In FY2025, financing inflows of $112.3M exceeded the year-end cash balance of $102.9M, which means nearly the whole cash stock was assembled from outside capital while operating cash flow remained negative. That liquidity cushion sits beside negative equity of -$93.6M because liabilities of $199.7M still outrun assets, so near-term cash comfort and long-run balance-sheet strength are telling different stories.

The business changed scale abruptly: total assets moved from $134K in FY2024 to $106.1M in FY2025, and shares outstanding more than doubled, pointing to a recapitalization rather than a normal operating ramp. Within that new cost base, SG&A at $32.3M dwarfed R&D at $1.4M, so the FY2025 loss looks more tied to overhead and corporate activity than to product development spending.

Short-term liquidity looks unusually strong because cash of $102.9M sits against only $3.2M of current liabilities, leaving little sign of immediate payment pressure. But operating cash burn was -$10.3M after a much smaller -$42K burn in FY2024, so the enlarged balance sheet has not yet shown self-supporting cash generation.

Financial Health Signals

Financial health score pending refresh

We are recalculating Terra Innovatum Global's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Interest Coverage At Risk

-23.6x

Terra Innovatum Global earns $-23.6 in operating income for every $1 of interest expense (-$33.7M vs $1.4M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

-$33.7M

Terra Innovatum Global's EBITDA was -$33.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Net Income

N/A

EPS (Diluted)

$9.74

Terra Innovatum Global earned $9.74 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$102.9M

YoY+149004.3%

Terra Innovatum Global held $102.9M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

110M

YoY+132.1%

Terra Innovatum Global had 110M shares outstanding in fiscal year 2025. This represents an increase of 132.1% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

$1.4M

YoY+1750.7%

Terra Innovatum Global invested $1.4M in research and development in fiscal year 2025. This represents an increase of 1750.7% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

NKLR Income Statement

Metric	FY25	FY26
Revenue	N/A	N/A
Cost of Revenue	N/A	N/A
Gross Profit	N/A	N/A
R&D Expenses	$1.4M+1750.7%	$75K
SG&A Expenses	$32.3M+41324.4%	$78K
Operating Income	-$33.7M-21925.5%	-$153K
Interest Expense	$1.4M	N/A
Income Tax	N/A	$10K
Net Income	N/A	-$34K
EPS (Diluted)	$9.74	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$1.2M	N/A	$155K	N/A	$33K	N/A	$16K	N/A
SG&A Expenses	$5.4M	N/A	$2.1M	N/A	$1.4M	N/A	$2K	N/A
Operating Income	-$6.6M	N/A	-$2.3M	N/A	-$1.4M	N/A	-$18K	N/A
Interest Expense	N/A	N/A	$537K	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$7.1M	N/A	-$3.0M-160.9%	-$1.1M+20.9%	-$1.4M	N/A	$16K-20.0%	$20K
EPS (Diluted)	$-0.06	N/A	N/A	N/A	$-0.03	N/A	N/A	N/A

NKLR Balance Sheet

Metric	FY25	FY26
Total Assets	$106.1M+79106.0%	$134K
Current Assets	$106.0M+79029.9%	$134K
Cash & Equivalents	$102.9M+149004.3%	$69K
Inventory	N/A	N/A
Accounts Receivable	$4K	N/A
Goodwill	N/A	N/A
Total Liabilities	$199.7M+120216.9%	$166K
Current Liabilities	$3.2M+5860.4%	$53K
Long-Term Debt	N/A	N/A
Total Equity	-$93.6M-292368.8%	-$32K
Retained Earnings	-$607.3M-1641186.5%	-$37K

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$101.9M-4.0%	$106.1M+2731.8%	$3.7M	N/A	N/A	$134K	N/A	N/A
Current Assets	$101.5M-4.3%	$106.0M+2805.0%	$3.6M	N/A	N/A	$134K	N/A	N/A
Cash & Equivalents	$96.7M-6.0%	$102.9M+4683.0%	$2.2M	N/A	$44K-36.2%	$69K+392.9%	$14K	N/A
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	$4K	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$200.6M+0.4%	$199.7M+2403.5%	$8.0M	N/A	N/A	$166K	N/A	N/A
Current Liabilities	$4.8M+50.5%	$3.2M-57.8%	$7.5M	N/A	N/A	$53K	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$98.7M-5.5%	-$93.6M-2112.5%	-$4.2M-178.5%	-$1.5M-3.1%	-$1.5M-4506.3%	-$32K-150.0%	$64K+236.8%	$19K
Retained Earnings	-$614.4M-1.2%	-$607.3M-10711.4%	-$5.6M	N/A	N/A	-$37K	N/A	N/A

NKLR Cash Flow Statement

Metric	FY25	FY26
Operating Cash Flow	-$10.3M-24416.7%	-$42K
Capital Expenditures	N/A	N/A
Free Cash Flow	N/A	N/A
Investing Cash Flow	-$108K	N/A
Financing Cash Flow	$112.3M+100134.8%	$112K
Dividends Paid	N/A	N/A
Share Buybacks	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$3.9M+41.7%	-$6.6M	N/A	N/A	-$199K-268.5%	-$54K	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$328K-2242.9%	-$14K	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	$106.5M	N/A	N/A	$172K	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

NKLR Financial Ratios

Metric	FY25	FY26
Gross Margin	N/A	N/A
Operating Margin	N/A	N/A
Net Margin	N/A	N/A
Return on Equity	N/A	N/A
Return on Assets	N/A	-25.4%
Current Ratio	33.57+31.0	2.53
Debt-to-Equity	N/A	N/A
FCF Margin	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	25.0%-80.3pp	105.3%
Return on Assets	-7.0%	N/A	-79.7%	N/A	N/A	N/A	N/A	N/A
Current Ratio	21.34-12.2	33.57+33.1	0.49	N/A	N/A	2.53	N/A	N/A
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$93.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Frequently Asked Questions

What is Terra Innovatum Global's EBITDA?

Terra Innovatum Global (NKLR) had EBITDA of -$33.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Terra Innovatum Global's operating cash flow?

Terra Innovatum Global (NKLR) generated -$10.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Terra Innovatum Global's total assets?

Terra Innovatum Global (NKLR) had $106.1M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Terra Innovatum Global spend on research and development?

Terra Innovatum Global (NKLR) invested $1.4M in research and development during fiscal year 2025.

How many shares does Terra Innovatum Global have outstanding?

Terra Innovatum Global (NKLR) had 110M shares outstanding as of fiscal year 2025.

What is Terra Innovatum Global's current ratio?

Terra Innovatum Global (NKLR) had a current ratio of 33.57 as of fiscal year 2025, which is generally considered healthy.

What is Terra Innovatum Global's cash runway?

Based on fiscal year 2025 data, Terra Innovatum Global (NKLR) had $102.9M in cash against an annual operating cash burn of $10.3M. This gives an estimated cash runway of approximately 120 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Terra Innovatum Global's debt-to-equity ratio negative or not reported?

Terra Innovatum Global (NKLR) has negative shareholder equity of -$93.6M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Can Terra Innovatum Global cover its interest payments?

Terra Innovatum Global (NKLR) has an interest coverage ratio of -23.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.